id,label,action
1,Consider genetic testing for CYP2C19 to rule out any drug-gene interactions with Clopidegrol the patient may have,
2,Current evidence does not support testing of these genes to guide Clopidegrol therapy. Consider genetic testing for CYP2C19 to rule out any drug-gene interactions with Clopidegrol the patient may have,
3,"Consult with the patient's care team as clopidogrel, prasugrel and ticagrelor are ALL contraindicated in this patient.",
4,"If CYP2C19 UM, RM or NM: Use clopidogrel at the label recommended dose.
If CYP2C19 IM, LIM, LPM or PM: Consider prasugrel instead of clopidogrel or ticagrelor in this patient.",
5,"If CYP2C19 UM, RM or NM: Use clopidogrel at the label recommended dose. If CYP2C19 IM, LIM, LPM or PM: Consider either prasugrel or ticagrelor instead of clopidogrel in this patient.",
6,
